Sleep Apnea, Central Terminated Phase 3 Trials for Oxygen (DB09140)

Also known as: Central Sleep Apnea / Sleep Apnea Central / Central sleep apnoea syndrome / Central sleep apnea syndrome (disorder) / Central sleep apnea syndrome

IndicationStatusPhase
DBCOND0003369 (Sleep Apnea, Central)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03745898The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep ApneaTreatment